Kaléo is looking forward to joining the food allergy community at the FAACT Allergy Summit! We’re proud to be part of conversations advancing food allergy awareness, education, and preparedness for people living with severe food allergies and those who care for them.

Kaléo has been awarded a contract by @BARDA to support the late-stage development, regulatory approval, and initial procurement of the next-generation 2-PAM auto-injector for U.S. chemical threat preparedness. Read the announcement: bit.ly/4j9aHQ8

The Kaléo team is in San Diego for #AAPExperience! We’re excited to connect with pediatric healthcare professionals and join important conversations around advancing care for children and families. If you’re attending, we hope to see you there.

Not every medicine is simple to deliver. Higher viscosities and complex formulations can create unique challenges. The Aerio™ Auto-Injector Platform was designed with flexibility in mind to support a range of drug delivery needs. Explore more: kaleo.com/aerio/

Kaléo named a nominee for the Inaugural 2026 Prix Galien Patient First Award in Honor of Michael J. Fox in the Private Sector Initiatives Category. Read more: bit.ly/3V9wBbR @GalienFdn

Emergency threats continue to evolve and meeting those challenges requires technologies designed for demanding environments. Learn how Kaléo is working to help advance medical countermeasures for the frontlines. Learn more: kaleo.com/mcm

For healthcare professionals: Did you know Kaléo’s Medical Affairs website offers educational & scientific resources on anaphylaxis? Explore peer-reviewed publications, evidence-based resources, and information to use with patients and caregivers. kaleomedicalaffairs.com/

For the past 25 years, Kaléo has been guided by a simple purpose: showing up for others when it matters most. Our anniversary video highlights the people, purpose, and responsibility behind our work. #BuiltToTrust

License Agreement: Amgen obtained a license to certain of Kaléo's patented technology on auto-injectors, reflecting Kaléo's innovative contribution to drug-device technologies. Read the full announcement: bit.ly/4xjWBz9

Anaphylaxis can look different in infants and toddlers, making it harder to recognize and treat. Two new papers examine potential barriers to timely recognition and treatment, and explore opportunities to improve preparedness. bit.ly/4pZLJE8 #FoodAllergy #Pediatrics

Summer camp brings new adventures and important conversations for families managing food allergies. Kids with Food Allergies @kfatweets shares practical tips to help campers, caregivers, and staff prepare for a safer summer. Explore the guide: bit.ly/4dgVoSd

We're in San Diego for #BIO2026. Schedule a meeting through the BIO Partnering system to explore the Aerio™ Auto-Injector Platform—Kaléo's drug-delivery platform, Developed by Patients, for Patients™. #DrugDelivery #Biotech

Across the severe allergy landscape, the need for greater awareness and preparedness remains essential. At a time when food allergies are in focus, we’re launching a new initiative centered on real-world experiences. Learn more: bit.ly/3Rp0K5k

This Asthma & Allergy Awareness Month, we’re proud to sponsor premiere events for “May Contain,” the award-winning docudrama highlighting the real experiences of children and families navigating food allergies and anaphylaxis. Learn more: bit.ly/3RCl6b7

Food allergy bullying is more common than many realize & often goes unspoken. As conversations around food allergies continue this May, this episode of The Itch Podcast explores the signs & how to start meaningful conversations with children and schools. bit.ly/48d0BHA

Food Allergy Awareness Month is here. FAACT's #InvisibleNoMore campaign offers educational resources and tools to help patients, families, and communities raise awareness of food allergy safety. Explore the campaign and get involved. bit.ly/4ezqrcY

Kaléo’s Medical Affairs team will be attending the Pediatric Academic Societies (PAS) meeting in Boston this April. If you’ll be there, stop by booth 327 to connect.

The Kaléo team will be at CBRNe Convergence Canada 2026. Attending? Let’s connect about device innovation and real-world usability in critical environments.

One platform. Three configurations. The Aerio™ Auto-Injector Platform is designed to meet the highest standards of device function and form while supporting a range of drug delivery needs: Aerio™Uno Aerio™Duo Aerio™Mix Learn more: kaleo.com/aerio/ #BuiltToTrust

One platform. Three configurations. The Aerio™ Auto-Injector Platform is designed to meet the highest standards of device function and form while supporting a range of drug delivery needs: Aerio™Uno Aerio™Duo Aerio™Mix Learn more: kaleo.com/aerio/ #BuiltToTrust